Evidence map›Paper›PMID 34993861›Full record

ArticleJournal of general internal medicine2022

Patient Perspectives on Improving Patient-Provider Relationships and Provider Communication During Opioid Tapering.

Sarah Kosakowski, Allyn Benintendi, Pooja Lagisetty, Marc R Larochelle, Amy S B Bohnert, Angela R Bazzi

Abstract read
In one paragraph

Article in Journal of general internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sarah KosakowskiClinical Addiction Research and Evaluation Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA.
Allyn BenintendiClinical Addiction Research and Evaluation Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA.
Pooja LagisettyMichigan Medicine, Department of Internal Medicine, Ann Arbor, MI, USA.
Marc R LarochelleClinical Addiction Research and Evaluation Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA.
Amy S B BohnertVA Center for Clinical Management Research, Ann Arbor, MI, USA.
Angela R BazziHerbert Wertheim School of Public Health and Human Longevity Science, University of California, La Jolla, CA, USA. abazzi@health.ucsd.edu.

Funding

A Tailored Behavioral Intervention To Increase Engagement in Opioid Tapering in Primary Care SettingsK23DA047475 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAGISETTY, POOJA · 2019 to 2023
$970k
Improving urine drug test utility to mitigate prescription opioid riskK23DA042168 · NIDA · BOSTON MEDICAL CENTER · PI LAROCHELLE, MARC · 2017 to 2021
$956k
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
Heroin use and overdose following changes to individual-level opioid prescribingU01CE002780 · CE · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BOHNERT, AMY S B, LAROCHELLE, MARC · 2017 to 2018
$800k
NCIPC CDC HHS U01 CE002780NIDA NIH HHS K01 DA043412NIDA NIH HHS K23 DA042168NIDA NIH HHS K23 DA047475
6 · The paper itself

Abstract

backgroundEfforts to reduce opioid overdose fatalities have resulted in tapering (i.e., reducing or discontinuing) opioid prescriptions despite a limited understanding of patients' experiences.

objectiveTo explore patients' perspectives on opioid taper experiences to ultimately improve taper processes and outcomes.

designQualitative study.

participantsPatients on long-term opioid therapy for chronic pain who had undergone a reduction of opioid daily prescribed dosage of ≥50% in the past 2 years in two distinct medical systems and regions. APPROACH: From 2019 to 2020, we conducted semi-structured interviews that were audio-recorded, transcribed, systematically coded, and analyzed to summarize the content and identify key themes regarding taper experiences overall and with particular attention to patient-provider relationships and provider communication during tapers. KEY

resultsParticipants (n=41) had lived with chronic pain for an average of 17.4 years (range, 3-36 years) and described generally adverse experiences with opioid tapers, the initiation of which was not always adequately justified or explained to them. Consequences of tapers ranged from minor to substantial and included withdrawal, mobility issues, emotional distress, exacerbated mental health symptoms, and feelings of social stigmatization for which adequate supports were typically unavailable. Narratives highlighted the consequential role of patient-provider relationships throughout taper experiences, with most participants describing significant interpersonal challenges including poor provider communication and limited patient engagement in decision making. A few participants identified qualities of providers, relationships, and communication that fostered more positive taper experiences and outcomes.

conclusionsFrom patients' perspectives, opioid tapers can produce significant physical, emotional, and social consequences, sometimes reducing trust and engagement in healthcare. Patient-provider relationships and communication influence patients' perceptions of the quality and outcomes of opioid tapers. To improve patients' experiences of opioid tapers, tapering plans should be based on individualized risk-benefit assessments and involve patient-centered approaches and improved provider communication.

Indexed as

Analgesics, OpioidChronic PainCommunicationHumansProfessional-Patient RelationsQualitative ResearchAnalgesics, OpioidAnalgesics, opioidChronic painCommunicationProfessional-patient relationsTaper

Identifiers

PMID34993861
PMCPMC9130417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.